Back to School on Biosimilars

Today the FDA announced a new education and awareness campaign that will help physicians better understand the world of biosimilars. First, what is a biosimilar?

The (Tom) Price of Failure

Congress may have stalled out in deadlock over changes to our healthcare system but the executive branch is moving full steam ahead.  How will the